• 021-20985259

Shanghai Novamab Biopharmaceuticals Co., Ltd.

Shanghai Novamab Biopharmaceuticals Co., Ltd. (Novamab) is specialized in innovative nanobody new drugs and is devoted to developing better drugs for patients. Being operated since October 2017, Novamab has established laboratories and pilot field of over 1000 M2 in Shanghai International Medical Zone, including an integrated R&D platform for nanobody from discovery to IND enabling. With a professional and skillful team, Novamab has built a rich R&D pipeline covering oncology, ophthalmic diseases, autoimmune diseases, and cardiovascular diseases, along with 7 Chinese and one PCT patents filed.

With a high level nanobody research background, Novamab has been establishing an integrated, systemic and global R&D platform including nanobody discovery, pre-clinical and clinical stages, overall realizing the medical value of nanobody.

Shanghai Novamab Biopharmaceuticals Co., Ltd. Technical support:朗企科技